ADARx Pharmaceuticals raises $446.3 million in upsized US IPO

ADARx Pharmaceuticals said on Thursday it had raised $446.3 million in an upsized US initial public offering, reflecting ​growing investor appetite for biotech listings.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。